Details for 2017192138

Up to date per 08.05.2026

Actions

Title / Product Name

KRISTALLINE FORM VON N-[5-(3,5-DIFLUOR-BENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-BENZAMID

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017192138

EP Publication Number

3290414

E-Number

1158016

Language

PCT Number

Publication Date

07.03.2018 A

24.07.2019 B1

Registration Date

24.07.2019

AT Publication Date

15.08.2019

Application Date

22.05.2013

Registration Number

Priorities

23.05.2012

12169139

IPC

C07D 405/12 20060101AFI20171219BHEP

Maximum Duration of Protection

22.05.2033

Owner

NERVIANO MEDICAL SCIENCES S.R.L.Viale Pasteur, 10 20014 Nerviano (MI)IT

Representative

No representatives present

Inventor

BARBUGIAN, Natale AlvaroVia Giovanni Pascoli, 7 20037 Paderno Dugnano (MI)IT

FORINO, RomualdoVia Del Caravaggio, 14 20144 MilanIT

FUMAGALLI, TizianoVia Dante 46 20069 Trezzano Rosa (MI)IT

ORSINI, PaoloVia Padova, 5 20025 Legnano (MI)IT

Information about Fees